P1.22. Predictive Biomarkers of Response to REGN5093 to Guide Patient Selection in MET-Altered Advanced Non-small Cell Lung Cancer - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Mary Laughlin
Meta Tag
Speaker Mary Laughlin
Topic Pathology & Biomarkers: Genetic Biomarkers
predictive biomarkers
advanced NSCLC
tumor response
MET alterations
MET exon 14 mutations
MET amplification
genomic mutations
circulating tumor DNA
combination therapies
Powered By